Please complete the CAPTCHA to continue
A concise factual answer block for searchers comparing this professional profile.
Marc Cerrada-Gimenez is listed as Seasoned Lead Scientist & Project Manager | Expertise in Preclinical Drug Development, R&D Implementation, and Team Leadership at EXPERIMENTICA, a with 34 employees, based in Kuopio, Northern Savonia, Finland. AeroLeads shows a matched LinkedIn profile for Marc Cerrada-Gimenez.
Marc Cerrada-Gimenez previously worked as Principal Scientist at Experimentica and Chief Technology Officer at Experimentica. Marc Cerrada-Gimenez holds Doctor Of Philosophy (Phd), Biotechnology from University Of Eastern Finland.
This section adds company-level context without repeating Marc Cerrada-Gimenez's masked contact details.
Review company-level records connected to Marc Cerrada-Gimenez before choosing the right outreach path.
As a seasoned Lead Scientist and Project Manager with over 15 years of experience, I have dedicated my career to driving success in preclinical drug development and R&D implementation. My journey has been marked by a passion for innovation, strategic efficiency enhancements, and a commitment to excellence in team leadership and project management.Currently, I serve as Principal Scientist at Experimentica Ltd. My contributions, in leadership, strategic efficiency improvements, and implementation of novel models have been pivotal in increasing company's turnover. In this role, I manage an average of 30 preclinical drug discovery projects annually, ensuring meticulous alignment with client requirements and delivering detailed reports to stakeholders across the globe.Throughout my career, I have consistently embraced technological innovation. As Chief Technology Officer at Experimentica, we developed AI-powered bio-image analysis tools, significantly reducing analysis time and enhancing experimental robustness. This achievement positioned our company as a leader in bio-image analysis within the ophthalmic preclinical research sector.My tenure at Minoryx Therapeutics involved critical contributions to preclinical data preparation for Investigational New Drug (IND) applications, resulting in the Orphan Drug Designation by both the U.S. FDA and the EMA. My expertise in biomarker identification and validation was instrumental in advancing Phase 1 and Phase 2/3 clinical trials, thereby enhancing efficacy and safety assessments.With a strong background in financial management, process standardization, and scientific reporting, I have successfully managed the preclinical research in consortium projects funded by the European Council. My comprehensive skill set includes strategic planning, efficiency enhancement, translational research, statistical analysis, and grant management.Fluent in Spanish and English, and limited proficiency in Finnish, I am well-equipped to engage with diverse teams and stakeholders. My commitment to advancing scientific research and development drives me to continually seek opportunities to innovate and excel in the biotechnology field.Let's connect and explore how we can collaborate to push the boundaries of scientific discovery and innovation.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Finland
Lead a multidisciplinary team in executing cutting-edge preclinical ophthalmic drug discovery projects, leveraging advanced methodologies and fostering a culture of scientific excellence. Spearheaded initiatives that resulted in increase project throughput and improvement in data accuracy and reproducibility.
Kuopio, Northern Savonia, Finland
Oversaw the development and integration of AI-powered bio-image analysis tools, reducing analysis time by 80% and enhancing robustness across experiments. Championed the implementation and optimization of data management processes.
Kuopio Area, Finland
Directed the implementation of strategic R&D initiatives, aligning projects with corporate objectives and regulatory requirements. Successfully managed the preclinical parts of European Council-funded projects, ensuring timely delivery and adherence to budgetary constraints.
Kuopio, Northern Savonia, Finland
Led in vivo pharmacology studies, developing and validating novel animal models for drug efficacy and safety testing. Implemented process improvements that enhanced study efficiency, reducing project timelines and costs.
Kuopio, Eastern Finland, Finland
Conducted comprehensive preclinical research, contributing to the identification and validation of novel biomarkers for drug development. Developed and optimized experimental protocols, resulting in increased data reliability and consistency.
Mataró, Catalonia, Spain
Regulatory Compliance and Documentation: Played a crucial role in preparing preclinical data for the Investigational New Drug (IND) application and Investigator’s Brochure, leading to the granting of Orphan Drug Designation by both the U.S. Food and Drug Administration (FDA) and European Medicine Agency (EMA) for a novel compound.Biomarker Identification: Identified and validated translational biomarkers critical for Phase 1 and Phase 2/3 clinical trials, enhancing efficacy and safety… Show more Regulatory Compliance and Documentation: Played a crucial role in preparing preclinical data for the Investigational New Drug (IND) application and Investigator’s Brochure, leading to the granting of Orphan Drug Designation by both the U.S. Food and Drug Administration (FDA) and European Medicine Agency (EMA) for a novel compound.Biomarker Identification: Identified and validated translational biomarkers critical for Phase 1 and Phase 2/3 clinical trials, enhancing efficacy and safety assessments throughout the drug development process. Show less
Kuopio, Northern Savonia, Finland
Spearheaded the expansion of biomarker and in vitro lab services, introducing advanced analytical techniques and novel assays that increased the breadth of service offerings. This initiative contributed significantly to the increase in company turnover, and enhanced the company’s market competitiveness.
Kuopio, Northern Savonia, Finland
Conducted pivotal biomarker discovery and validation studies, leading to the development of new diagnostic tools and therapeutic strategies. Successfully optimized laboratory protocols, resulting in increased experimental throughput and a reduction in resource utilization.
Kuopio, Finland
Mouse colony management and responsible for all the ex vivo analysis aimed to the characterization of transgenic mice expressing a mutation in the Sulfonylurea Receptor 1 (SUR1).
Barcelona Y Alrededores, España
Characterization of various transgenic mouse models for type 2 diabetes.
Kuopio, Finland
Research assistant working in the characterization of various Nuclear Receptors.
Other employees you can reach at experimentica.com. View company contacts for 34 employees →
Dovilė Litvinavičiūtė
Colleague at ExperimenticaVilnius, Vilniaus, Lithuania
View →
JJ
Jenni J. Hakkarainen
Colleague at ExperimenticaKuopio, Northern Savonia, Finland
View →
AT
Arina Timonina
Colleague at ExperimenticaKuopio, Northern Savonia, Finland
View →
RV
Roberta Vasiliauskaitė
Colleague at ExperimenticaVilnius, Vilniaus, Lithuania
View →
BL
Birgitta Lappeteläinen
Colleague at ExperimenticaSiilinjärvi, Northern Savonia, Finland
View →
SR
Symantas Ragauskas
Colleague at ExperimenticaLithuania
View →
AF
Anu Finne
Colleague at ExperimenticaKuopio, Northern Savonia, Finland
View →
HN
Hajnalka Nádai
Colleague at ExperimenticaFinland
View →
JU
Justina Urbanavičiūtė
Colleague at ExperimenticaVilnius, Vilniaus, Lithuania
View →
MV
Maria Vähätupa
Colleague at ExperimenticaKuopio, Northern Savonia, Finland
View →
Activities and Societies: 2007. Co-Chair in the Gordon Graduate Research Seminar: Polyamines Thesis title: "Development and use of tools.
Quick answers generated from the profile data available on this page.
Marc Cerrada-Gimenez works for EXPERIMENTICA.
Marc Cerrada-Gimenez is listed as Seasoned Lead Scientist & Project Manager | Expertise in Preclinical Drug Development, R&D Implementation, and Team Leadership at EXPERIMENTICA.
Marc Cerrada-Gimenez is based in Kuopio, Northern Savonia, Finland while working with EXPERIMENTICA.
Marc Cerrada-Gimenez has worked for Experimentica, Experimentica Ltd, Minoryx Therapeutics, Charles River Laboratories, and Dept. Of Internal Medicine. University Of Eastern Finland.
Marc Cerrada-Gimenez's colleagues at EXPERIMENTICA include Dovilė Litvinavičiūtė, Jenni J. Hakkarainen, Arina Timonina, Roberta Vasiliauskaitė, and Birgitta Lappeteläinen.
You can use AeroLeads to view verified contact signals for Marc Cerrada-Gimenez at EXPERIMENTICA, including work email, phone, and LinkedIn data when available.
Marc Cerrada-Gimenez holds Doctor Of Philosophy (Phd), Biotechnology from University Of Eastern Finland.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts